Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
21 12 2022
Historique:
pubmed: 13 10 2022
medline: 28 12 2022
entrez: 12 10 2022
Statut: ppublish

Résumé

Enterovirus A71 (EV-A71) is a causative agent of life-threatening neurological diseases in young children. EV-A71 is highly infectious but it remains unclear how the virus disseminates from primary entry sites-the mucosa of the respiratory tract or the intestine-to secondary replication sites-skin or brain. Here, we investigated the role of dendritic cells (DCs) in EV-A71 dissemination. DCs reside in the mucosa of the airway and gut, and migrate to lymphoid tissues upon activation and, therefore, could facilitate EV-A71 dissemination to secondary replication sites. Monocyte-derived DCs were not permissive to different genotypes of EV-A71 but, notably, coculture with EV-A71-susceptiblle RD99 cells led to very efficient infection of RD99 cells. Notably, EV-A71 transmission of DCs to RD99 was independent of viral replication as a replication inhibitor did not affect transmission. Soluble heparin blocked EV-A71 transmission by DCs to RD99 cells, in contrast to antibodies against known attachment receptor DC-SIGN. These results strongly suggest that DCs might be a first target for EV-A71 and involved in viral dissemination via heparan sulfates and heparin derivatives might be an effective treatment to attenuate dissemination.

Identifiants

pubmed: 36222686
doi: 10.1128/spectrum.02822-22
pmc: PMC9769767
doi:

Substances chimiques

Antigens, Viral 0
Heparin 9005-49-6
Heparitin Sulfate 9050-30-0
Sulfates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282222

Auteurs

Leanne C Helgers (LC)

Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.

Michel S Bhoekhan (MS)

Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.

Dasja Pajkrt (D)

Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Katja C Wolthers (KC)

Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Teunis B H Geijtenbeek (TBH)

Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.

Adithya Sridhar (A)

Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH